GSK PLC (LSE:GSK)
£ 13.97 0.16 (1.16%) Market Cap: 57.00 Bil Enterprise Value: 69.85 Bil PE Ratio: 22.90 PB Ratio: 4.07 GF Score: 69/100

Q2 2023 GSK plc Earnings Call Transcript

Jul 26, 2023 / 11:00AM GMT
Release Date Price: £13.85 (-0.55%)
Nick Stone

Hello, everyone. Welcome to our half year and Q2 2023 conference call and webcast for investors and analysts. The presentation was sent to our distribution list by e-mail, and you can also find it on gsk.com.

Please turn to Slide 2. This is the usual safe harbor statement. We'll comment on our performance using constant exchange rates, or CER, unless stated otherwise. As a reminder, following the Consumer Healthcare demerger in 2022 to form Haleon, we're presenting performance and growth from the continuing operations for GSK.

Please turn to Slide 3. Today's call will last approximately 1 hour and management presentation will take between 30 to 35 minutes with the remaining time for your questions. (Operator Instructions) Our speakers today are Emma Walmsley, Tony Wood, Luke Miels, Deborah Waterhouse and Julie Brown, with David Redfern joining the rest of the team for the Q&A portion of the call.

Turning to Slide 4. I will now hand the call over to Emma.

Emma Natasha Walmsley
GSK plc - CEO & Director

Thanks, Nick, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot